Market Overview

BMO Capital Markets Reiterates Outperform Rating, $45 PT for Cenovus Energy

Share:
Related CVE
Mid-Afternoon Market Update: Crude Oil Up Over 2%; Alnylam Pharma Shares Climb After Positive Phase 3 Results
A Peek Into The Markets: U.S. Stock Futures Drop Ahead Of Fed Speakers

In a report published earlier today, BMO Capital Markets reiterated its Outperform rating and $45.00 price target for Cenovus Energy Incorporated (NYSE: CVE).

BMO Capital went on to say “We are maintaining our 2012 earnings estimate of $1.93/share and our 2013 estimate of $1.59. Our outlook assumes that production averages 262,489 boe/d and 281,308 boe/d, respectively...Cenovus is our top investment recommendation in the group based on (1) proven execution capabilities (2) industry-leading cash operating and supply costs (3) projected 5-year CAGR in net asset value of 14%. Our $45 target price implies a 2013E EV/EBITDA of 10.2x and is roughly in line with our risked 2012 net asset value estimate of $45.63.”

Cenovus Energy Incorporated closed on Friday at $31.46.

Latest Ratings for CVE

DateFirmActionFromTo
Jun 2017National Bank FinancialInitiates Coverage OnSector Perform
Jun 2017Goldman SachsReinstatesNeutral
Jan 2017MacquarieDowngradesNeutralUnderperform

View More Analyst Ratings for CVE
View the Latest Analyst Ratings

Posted-In: BMO Capital MarketsAnalyst Color Reiteration Analyst Ratings

 

Related Articles (CVE)

View Comments and Join the Discussion!
Loading...
Loading...